Biosample Core The overarching mission of the GI SPORE Biosample Core is to collect, catalogue and distribute human biological samples with associated pertinent clinical data to the projects to facilitate translation research and help them accomplish their specific aims. The Biosample Core will be housed and administered within the Department of Pathology to ensure uncompromised patient care and confidentiality. The explicit goals of the Biosample Core include: (1) Uncompromised pathology diagnosis and patient care. Tissues will collected with informed consent imder IRB-approved protocols and patient confidentiality will be protected. (2) Prospective procurement and processing of colonic and pancreatic tissues from resection specimens. The Biosample Core with work closely with and enhance the existing Tissue Procurement Service to obtain highquality tissue samples not needed for diagnosis. (3) Prospective collection of blood and serum from patients with colorectal and pancreatic cancer, both pre-operative and post-operative. (4) Expert pathology review of colonic and pancreatic tissues. Internationally recognized colonic and pancreatic patiiologists will review all collected tissues and assist with selection of tissues for tissue array construction and interpretation of immunohistochemically-stained slides. (4) Data management. Pertinent pathologic and clinical information will be collected and managed in conjunction with GI SPORE Biostatistics and Bioinformatics Core and the Bioinformatics Group at Dartmouth Medical College. (5) Tissue array construction for validation studies. In conjunction with the UMCCC Tissue Core, the Biosample Core will construct colonic and pancreatic tissue arrays from archival pathology material. (6) Assist in tissue-based gene expression and biomarker validation studies, such as immunohistochemistry and automated in situ protein detection. Collectively, the many services of the GI SPORE Biosample Core will facilitate translational research and enhance the resources of other NCI-supported networks and groups.

National Institute of Health (NIH)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Ann Arbor
United States
Zip Code
Xue, Xiang; Ramakrishnan, Sadeesh K; Shah, Yatrik M (2014) Activation of HIF-1? does not increase intestinal tumorigenesis. Am J Physiol Gastrointest Liver Physiol 307:G187-95
Rho, Jung-hyun; Mead, Judson R; Wright, W Shea et al. (2014) Discovery of sialyl Lewis A and Lewis X modified protein cancer biomarkers using high density antibody arrays. J Proteomics 96:291-9
Veloso, Artur; Kirkconnell, Killeen S; Magnuson, Brian et al. (2014) Rate of elongation by RNA polymerase II is associated with specific gene features and epigenetic modifications. Genome Res 24:896-905
Cierpicki, Tomasz; Grembecka, Jolanta (2014) Challenges and opportunities in targeting the menin-MLL interaction. Future Med Chem 6:447-62
Kanwar, Shailender Singh; Dunlay, Christopher James; Simeone, Diane M et al. (2014) Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip 14:1891-900
Xie, Liwei; Xue, Xiang; Taylor, Matthew et al. (2014) Hypoxia-inducible factor/MAZ-dependent induction of caveolin-1 regulates colon permeability through suppression of occludin, leading to hypoxia-induced inflammation. Mol Cell Biol 34:3013-23
Dame, Michael K; Jiang, Yan; Appelman, Henry D et al. (2014) Human colonic crypts in culture: segregation of immunochemical markers in normal versus adenoma-derived. Lab Invest 94:222-34
Jiang, Yan; Djuric, Zora; Sen, Ananda et al. (2014) Biomarkers for personalizing omega-3 fatty acid dosing. Cancer Prev Res (Phila) 7:1011-22
Nie, Song; Lo, Andy; Wu, Jing et al. (2014) Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. J Proteome Res 13:1873-84
Yoon, Hyeun Joong; Kozminsky, Molly; Nagrath, Sunitha (2014) Emerging role of nanomaterials in circulating tumor cell isolation and analysis. ACS Nano 8:1995-2017

Showing the most recent 10 out of 28 publications